A detailed history of Wolverine Trading, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wolverine Trading, LLC holds 4,257 shares of AMGN stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,257
Previous 154,200 97.24%
Holding current value
$1.12 Million
Previous $48.2 Million 97.15%
% of portfolio
0.0%
Previous 0.05%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $1.32 Million - $1.44 Million
4,257 New
4,257 $1.37 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $4.29 Million - $5.18 Million
-15,973 Reduced 10.9%
130,537 $37.1 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $37.5 Million - $42.3 Million
146,510 New
146,510 $42.2 Million
Q2 2023

Aug 23, 2023

BUY
$214.27 - $253.37 $1.09 Million - $1.29 Million
5,105 Added 61.23%
13,442 $2.98 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $39.8 Million - $48.5 Million
-176,116 Reduced 95.48%
8,337 $2.01 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $34 Million - $43.2 Million
148,538 Added 413.58%
184,453 $48.4 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $943,180 - $1.06 Million
-4,202 Reduced 10.47%
35,915 $8.2 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $2.93 Million - $3.26 Million
12,697 Added 46.31%
40,117 $9.85 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $6.01 Million - $6.65 Million
27,420 New
27,420 $6.65 Million
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $5.82 Million - $6.66 Million
-29,272 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $6.21 Million - $7.28 Million
29,272 New
29,272 $6.29 Million
Q2 2021

Aug 06, 2021

SELL
$233.58 - $259.14 $4.01 Million - $4.45 Million
-17,153 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $4.9 Million - $5.71 Million
-22,068 Reduced 56.27%
17,153 $4.28 Million
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $2.99 Million - $3.56 Million
13,798 Added 54.27%
39,221 $8.91 Million
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $4.63 Million - $5.14 Million
19,712 Added 345.16%
25,423 $6.31 Million
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $3.29 Million - $4.03 Million
-16,621 Reduced 74.43%
5,711 $1.32 Million
Q1 2020

May 11, 2020

SELL
$182.24 - $241.7 $4.96 Million - $6.57 Million
-27,191 Reduced 54.91%
22,332 $4.66 Million
Q4 2019

Feb 12, 2020

BUY
$189.21 - $243.2 $2.97 Million - $3.82 Million
15,703 Added 46.43%
49,523 $11.9 Million
Q3 2019

Nov 14, 2019

BUY
$174.11 - $208.62 $5.7 Million - $6.83 Million
32,736 Added 3019.93%
33,820 $6.59 Million
Q2 2019

Aug 20, 2019

BUY
$166.7 - $195.41 $180,702 - $211,824
1,084 New
1,084 $200,000
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $6.85 Million - $7.72 Million
-37,875 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $3.38 Million - $3.95 Million
18,959 Added 100.23%
37,875 $7.22 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $1.49 Million - $1.67 Million
8,015 Added 73.53%
18,916 $3.92 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $1.85 Million - $2.16 Million
10,901 New
10,901 $1.86 Million
Q4 2017

Feb 14, 2018

SELL
$168.79 - $188.59 $3.72 Million - $4.16 Million
-22,046 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$167.29 - $191.0 $3.69 Million - $4.21 Million
22,046
22,046 $4.11 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.